Literature DB >> 11208350

Head trauma and neuroprotection.

Z Stelmasiak1, A Dudkowska-Konopa, K Rejdak.   

Abstract

Traumatic brain injury is a serious clinical problem connected with high mortality rate and long-term neurobehavioral and socioeconomic consequences. Pathomechanism of such insult is complex and not clear in all aspects as yet. Thus, a primary mechanistic insult to the brain initiates metabolic and inflammatory processes which exacerbate the primary traumatic injury to neurons, leading to secondary brain damage. In this paper we present the main components of destructive cascade with relevant theoretical strategy for neuroprotection. It should be emphasized that pathological processes involved in secondary brain damage are complex and interrelated. It makes blockade of a single mechanism unlikely to prevent either early or delayed cellular death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11208350

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  4 in total

1.  N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI.

Authors:  Jignesh D Pandya; Ryan D Readnower; Samir P Patel; Heather M Yonutas; James R Pauly; Glenn A Goldstein; Alexander G Rabchevsky; Patrick G Sullivan
Journal:  Exp Neurol       Date:  2014-05-01       Impact factor: 5.330

2.  Neuroprotective effect of ginseng total saponins in experimental traumatic brain injury.

Authors:  Yong Cheol Ji; Young Baeg Kim; Seung Won Park; Sung Nam Hwang; Byung Kook Min; Hyun Jong Hong; Jeong Taik Kwon; Jong Sik Suk
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

3.  Altered calcium signaling following traumatic brain injury.

Authors:  John T Weber
Journal:  Front Pharmacol       Date:  2012-04-12       Impact factor: 5.810

4.  Thioredoxin-Mimetic-Peptides Protect Cognitive Function after Mild Traumatic Brain Injury (mTBI).

Authors:  Renana Baratz-Goldstein; Hanna Deselms; Leore Raphael Heim; Lena Khomski; Barry J Hoffer; Daphne Atlas; Chaim G Pick
Journal:  PLoS One       Date:  2016-06-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.